1426 related articles for article (PubMed ID: 24691964)
21. The Zinc-dependent HDACs: Non-histone Substrates and Catalytic Deacylation Beyond Deacetylation.
Zheng W
Mini Rev Med Chem; 2022; 22(19):2478-2485. PubMed ID: 35362374
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylases: target enzymes for cancer therapy.
Mottet D; Castronovo V
Clin Exp Metastasis; 2008; 25(2):183-9. PubMed ID: 18058245
[TBL] [Abstract][Full Text] [Related]
23. Chemical probes for histone-modifying enzymes.
Cole PA
Nat Chem Biol; 2008 Oct; 4(10):590-7. PubMed ID: 18800048
[TBL] [Abstract][Full Text] [Related]
24. Non-sirtuin histone deacetylases in the control of cardiac aging.
Ferguson BS; McKinsey TA
J Mol Cell Cardiol; 2015 Jun; 83():14-20. PubMed ID: 25791169
[TBL] [Abstract][Full Text] [Related]
25. Class IIa histone deacetylases: regulating the regulators.
Martin M; Kettmann R; Dequiedt F
Oncogene; 2007 Aug; 26(37):5450-67. PubMed ID: 17694086
[TBL] [Abstract][Full Text] [Related]
26. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
28. Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.
Li Z; Zhu WG
Int J Biol Sci; 2014; 10(7):757-70. PubMed ID: 25013383
[TBL] [Abstract][Full Text] [Related]
29. Histone acetylation: plants and fungi as model systems for the investigation of histone deacetylases.
Graessle S; Loidl P; Brosch G
Cell Mol Life Sci; 2001 May; 58(5-6):704-20. PubMed ID: 11437232
[TBL] [Abstract][Full Text] [Related]
30. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
Sauve AA; Schramm VL
Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
[TBL] [Abstract][Full Text] [Related]
31. Deacetylation of chromatin and gene expression regulation: a new target for epigenetic therapy.
Olzscha H; Sheikh S; La Thangue NB
Crit Rev Oncog; 2015; 20(1-2):1-17. PubMed ID: 25746101
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylases and cancer: causes and therapies.
Marks P; Rifkind RA; Richon VM; Breslow R; Miller T; Kelly WK
Nat Rev Cancer; 2001 Dec; 1(3):194-202. PubMed ID: 11902574
[TBL] [Abstract][Full Text] [Related]
33. Global analysis of functional relationships between histone point mutations and the effects of histone deacetylase inhibitors.
Sato L; Noguchi S; Hayashi Y; Sakamoto M; Horikoshi M
Genes Cells; 2010 Jun; 15(6):553-94. PubMed ID: 20553507
[TBL] [Abstract][Full Text] [Related]
34. The emerging roles of HDACs and their therapeutic implications in cancer.
Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase activity assay.
Yuan Z; Rezai-Zadeh N; Zhang X; Seto E
Methods Mol Biol; 2009; 523():279-93. PubMed ID: 19381932
[TBL] [Abstract][Full Text] [Related]
36. Isoform-selective histone deacetylase inhibitors.
Itoh Y; Suzuki T; Miyata N
Curr Pharm Des; 2008; 14(6):529-44. PubMed ID: 18336298
[TBL] [Abstract][Full Text] [Related]
37. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
Hyndman KA
Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
[TBL] [Abstract][Full Text] [Related]
38. Small molecule inhibitors of zinc-dependent histone deacetylases.
Wagner FF; WeŃ—wer M; Lewis MC; Holson EB
Neurotherapeutics; 2013 Oct; 10(4):589-604. PubMed ID: 24101253
[TBL] [Abstract][Full Text] [Related]
39. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells.
Ganai SA; Kalladi SM; Mahadevan V
J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937
[TBL] [Abstract][Full Text] [Related]
40. Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates.
Yao YL; Yang WM
J Biomed Biotechnol; 2011; 2011():146493. PubMed ID: 21234400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
